Use of venetoclax combination regimens in chronic lymphocytic leukemia.

Authors :: Tam CS
Source :: Clinical advances in hematology & oncology : H&O [Clin Adv Hematol Oncol] 2021 Aug; Vol. 19 (8), pp. 504-506.
Publication Year :: 2021

Subjects :: Antineoplastic Agents adverse effects
Humans
Antineoplastic Combined Chemotherapy Protocols adverse effects
Bridged Bicyclo Compounds, Heterocyclic therapeutic use
Leukemia, Lymphocytic, Chronic, B-Cell drug therapy
Sulfonamides adverse effects

Tools